Agomelatine Is Unable to Attenuate Kainic Acid-Induced Deficits in Early Life Communicative Behavior

Area of Science:

• Neuroscience
• Developmental Biology
• Behavioral Science

Background:

• Early life seizures can lead to behavioral issues, including communication deficits.
• Auditory communication in mice, ultrasonic vocalizations (USVs), serve as a model for studying these deficits.
• Agomelatine is effective for adult seizure comorbidities but its neonatal efficacy is unknown.

Purpose of the Study:

• To investigate the effect of agomelatine on seizure-induced communication deficits in neonatal mice.
• To analyze changes in ultrasonic vocalizations (USVs) following kainic acid-induced seizures and agomelatine treatment.

Main Methods:

• Neonatal C57 mice received kainic acid (KA) or saline on postnatal day 10.
• Agomelatine or saline was administered 1 hour post-status epilepticus.
• Ultrasonic vocalizations (USVs) were analyzed on postnatal day 11 for quantity, duration, frequency, amplitude, and call type.

Main Results:

• Kainic acid (KA) increased USV production and duration, and altered call types, frequency, and amplitude.
• Agomelatine treatment did not reverse or attenuate any of the KA-induced USV deficits.
• This study is the first to evaluate agomelatine's effect on neonatal seizure-induced USV alterations.

Conclusions:

• Agomelatine's efficacy in correcting neonatal seizure-induced communication deficits, as measured by USVs, is limited.
• Despite effectiveness in adults, agomelatine does not appear to restore normal vocal communication in neonates after seizures.
• Further research is needed to understand and treat communication impairments following early-life seizures.